[EN] SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS<br/>[FR] COMPOSÉS SPIRO-OXADIAZOLINE EN TANT QU'AGONISTES DES RÉCEPTEURS DE L'ACÉTYLCHOLINE Α-7 NICOTINIQUE
申请人:FORUM PHARMACEUTICALS INC
公开号:WO2015066371A1
公开(公告)日:2015-05-07
The present invention relates to novel spiro-oxadiazoline compounds that are suitable as agonists or partial agonists of a7-nAChR, and pharmaceutical compositions of the same, methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering a spiro-oxadiazoline cx7-nAChR agonist or partial agonist, to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.
Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
申请人:Gruenenthal GmbH
公开号:US20040229872A1
公开(公告)日:2004-11-18
The use of substituted cyclohexan-1,4-diamine compounds in pharmaceutical compositions and for the treatment of diarrhea or irritable bowel diseases or as immunotherapeutic agents or peripheral analgesics, especially for treating burn pains, peripheral operation pains, pains generated by inflammation of soft tissues or inflammatory arthropathies, especially rheumatisms.
Substituted cyclohexane-1,4-diamine compounds, methods for production thereof, pharmaceutical compositions comprising these compounds and methods of treatment using these compounds.